Evaluation of Sarcopenia with F‐18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma

Ülkü Korkmaz, Mehmet Baysal, Sedanur Karaman Gülsaran, Volkan Baş, Ufuk Demirci, Gülay Durmuş Altun, Ahmet Muzaffer Demir

European Journal of Cancer Care · 2020 · 12 citations · 22 references

Abstract

Sarcopenia should be evaluated in every patient and regarded as a treatment target. FDG PET/CT is an easy and handy tool to assess muscle mass and quality as well as MM disease status.

References

22